Current Endovascular Management of Maxillofacial Vascular Malformations

Neuroimaging Clinics of North America

Volumn 17, Issue 2, 2007, Pages 223-237

  Niimi, Yasunari ^a   Song, Joon K ^a   Berenstein, Alejandro ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIOVENOUS SHUNT; CONGENITAL BLOOD VESSEL MALFORMATION; DISEASE CLASSIFICATION; EMBRYO DEVELOPMENT; HUMAN; LYMPHATIC SYSTEM DISEASE; MAXILLOFACIAL DISORDER; PRIORITY JOURNAL; REVIEW; SOFT TISSUE;

ARTERIOVENOUS MALFORMATIONS; CHILD; CHILD, PRESCHOOL; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MALE; MAXILLA; MAXILLARY ARTERY; MAXILLARY SINUS;

EID: 34447523272     PISSN: 10525149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nic.2007.02.002     Document Type: Review

References (47)

1. Folkman J., and D'Amore P.A. Blood vessel formation: what is its molecular basis?. Cell 87 (1996) 1153-1155
2. Burrows P.E., Mulliken J.B., Fellows K.E., et al. Childhood hemangiomas and vascular malformations: angiographic differentiation. AJR Am J Roentgenol 141 (1983) 483-488
3. Jackson I.T., Carreno R., Potparic Z., et al. Hemangiomas, vascular malformations, and lymphovenous malformations: classification and methods of treatment. Plast Reconstr Surg 91 (1993) 1216-1230
4. Mulliken J.B., and Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 69 (1982) 412-422
5. McAllister K.A., Grogg K.M., Johnson D.W., et al. Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasias type 1. Nat Genet 8 (1994) 345-351
6. Johnson D.W., Berg J.N., Baldwin M.A., et al. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasias type 2. Nat Genet 13 (1996) 441-443
7. Piantanida M., Buscarini E., Dellavecchia C., et al. Hereditary haemorrhagic telangiectasia with extensive liver involvement is not caused by either HHT1 or HHT2. J Med Genet 33 (1996) 441-443
8. Couly G., Coltey P., Eichmann A., et al. The angiogenetic potentials of the cephalic mesoderm and the origin of brain and head blood vessels. Mech Dev 53 (1995) 97-112
9. Bhattachaya J.J., Luo C.B., and Suh D.C. Wyburn-Mason or Bonnet-Dechume-Blanc as cerebrofacial arteriovenous metameric syndromes (CAMS): a new concept and new classification. Interventional Neuroradiology 7 1 (2001) 5-17
10. Yuh W.T., Buehner L.S., Kao S.C., et al. Magnetic resonance imaging of pediatric head and neck cystic hygromas. Ann Otol Rhinol Laryngol 100 (1991) 737-742
11. Berenstein A., Scott J., Choi I.S., et al. Percutaneous embolization of the arteriovenous fistulas of the external carotid artery. AJNR Am J Neuroradiol 7 (1986) 937-942
12. Persky M., and Berenstein A. Management of vascular lesions of the nose and paranasal sinuses. In: Goldman J. (Ed). The principles and practice of rhinology (1987), Churchill Livingstone, New York 569-580
13. Persky M.S., Yoo H.J., and Berenstein A. Management of vascular malformations of the mandible and maxilla. Laryngoscope 113 (2003) 1885-1892
14. Riles T.S., Berenstein A., Fisher F.S., et al. Reconstruction of the ligated external carotid artery for embolization of cervicofacial arteriovenous malformations. J Vasc Surg 17 (1993) 491-498
15. Waner M., and Suen J.Y. Treatment options for the management of hemangiomas. In: Waner M., and Suen J.Y. (Eds). Hemangiomas and vascular malformations of the head and neck (1999), Wiley-Liss, New York 233-261
16. Seccia A., Sakarello M., Farallo E., et al. Combined radiologic and surgical treatment of arteriovenous malformations of the head and neck. Ann Plast Surg 43 (1999) 359-366
17. Hubbell R.N., and Ihm P.S. Current surgical management of vascular anomalies. Curr Opin Otolaryngol Head Neck Surg 8 6 (2000) 441-447
18. Lee B.B., and Bergan J.J. Advanced management of congenital vascular malformations: a multidisciplinary approach. Cardiovasc Surg 10 6 (2002) 523-533
19. Burrows P.E., Lasjaunias P.L., Ter Brugge K.G., et al. Urgent and emergent embolization of lesions of the head and neck in children: indication and results. Pediatrics 80 (1987) 386-394
20. Goldberg R.A., Garcia G.H., and Duckwiler G.R. Combined embolization and surgical treatment of arteriovenous malformation of the orbit. Am J Opthalmol 116 (1993) 17-25
21. Marotta T.R., Berenstein A., and Zide B. The combined role of embolization and tissue expander in the management of arteriovenous malformations of the scalp. Am J Neuroradiol 15 (1994) 1240-1246
22. Chiras J., Hassine D., Goudot P., et al. Treatment of arteriovenous malformations of the mandible by arterial and venous embolization. AJNR Am J Neuroradiol 11 (1990) 1191-1194
23. Shultz R.E., Richardson D.D., Kempf K.K., et al. Treatment of a central arteriovenous malformation of the mandible with cyanoacrylate: a 4-year follow-up. Oral Surg Oral Med Oral Pathol 65 (1988) 267-271
24. Enjolras O., Mulliken J.B., Boon L.M., et al. A rare cutaneous anomaly. Plast Reconstr Surg 107 (2001) 1647-1654
25. Wisnicki J.L. Hemangiomas and vascular malformations. Ann Plast Surg 12 (1984) 41-59
26. Enjolras O., and Mulliken J.B. Clinical and laboratory investigations: the current management of vascular birthmarks. Pediatr Dermatol 10 4 (1993) 311-333
27. Eerola I., Boon L.M., Watanabe S., et al. Locus for susceptibility for familial capillary malformation ("port-wine stain") maps to 5q. Eur J Hum Genet 10 (2002) 375-380
28. Breugem C.C., Alders M., Salieb-Beugelaar G.B., et al. A locus for hereditary capillary malformations mapped on chromosome 5q. Hum Genet 110 (2002) 343-347
29. Eerola I., Boon L.M., Mulliken J.B., et al. Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet 73 (2003) 1240-1249
30. Vikkula M., Boon L.M., Carraway III K.L., et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 87 (1996) 1181-1190
31. Gallione C.J., Pasyk K.A., Boon L.M., et al. A gene for familial venous malformations maps to chromosome 9p in a second large kindred. J Med Genet 32 (1995) 197-199
32. Calvert J.T., Riney T.J., Kontos C.D., et al. Allelic and locus heterogeneity in inherited venous malformations. Hum Mol Genet 8 (1999) 1279-1289
33. Mulliken JB. Vascular birthmarks: hemangiomas and malformations. Philadelphia: Saunders; 1988. p. 301-42.
34. Burrows P.E., and Fellows K.E. Techniques for management of pediatric vascular anomalies. In: Cope C. (Ed). Current techniques in interventional radiology (1995), Current Medicine, Philadelphia 12-27
35. Dubois J.M., Sebag G.H., De Prost Y., et al. Soft-tissue venous malformations in children: percutaneous sclerotherapy with Ethibloc. Radiology 180 (1991) 195-198
36. Anavi Y., Har-El G., and Mintz S. The treatment of facial haemangioma by percutaneous injections of sodium tetradecyl sulfate. J Laryngol Otol 102 (1988) 87-90
37. De Lorimier A.A. Sclerotherapy for venous malformations. J Pediatr Surg 30 (1995) 188-193
38. Goebel W.M., and Lucatorto F.M. Sodium tetradecyl sulfate treatment of benign vascular anomalies. J Oral Med 31 (1976) 76-80
39. Yakes W.F., Haas D.K., Parker S.H., et al. Symptomatic vascular malformations: ethanol embolotherapy. Radiology 170 (1989) 1059-1066
40. Gelbert F., Enjolras O., Deffrenne D., et al. Percutaneous sclerotherapy for venous malformation of the lips: a retrospective study of 23 patients. Neuroradiology 42 9 (2000) 692-696
41. Waner M., and Suen J. Hemangiomas and vascular malformations of the head and neck (1999), Wiley-Liss, New York
42. Van der Putte S.C. The development of the lymphatic system in man. Adv Anat Embryol Cell Biol 51 (1975) 3-60
43. Gorenstein A., Katz S., Rein A., et al. Giant cystic hygroma associated with venous aneurysm. J Pediatr Surg 27 (1992) 1504-1506
44. Joseph A.E., Donaldson J.S., and Reynolds M. Neck and thorax venous aneurysm: association with cystic hygroma. Radiology 170 (1989) 109-112
45. Ogita S., Tsuto T., Deguchi E., et al. OK-432 therapy for unresectable lymphangiomas in children. J Pediatr Surg 26 (1991) 263-70
46. Giguere C.M., Bauman N.M., Sato Y., et al. Treatment of lymphangiomas with OK-432 (Picibanil) sclerotherapy: a prospective multi-institutional trial. Arch Otolaryngol Head Neck Surg 128 10 (2002) 1137-1144
47. Rautio R., Keski-Nisula L., Laranne J., et al. Treatment of lymphangiomas with OK-432 (Picibanil). Cardiovasc Intervent Radiol 26 1 (2003) 31-36